文献速递心外重症与机械循环支持

泵控逆流试验与动静脉桥接在VA-ECMO撤机中的比较

A comparison of pump-controlled retrograde trial off to arterio-venous bridging for weaning from venoarterial extracorporeal membrane oxygenation.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-29

本研究比较了泵控逆流试验(PCRTO)与动静脉桥接两种VA-ECMO撤机试验方法。回顾性分析51例患者,PCRTO组撤机试验时长显著短于AV桥接组(中位88.0 vs 196.6分钟,P<0.001),两组各死亡1例。结论认为PCRTO安全、简单、可重复,且避免了对ECMO管路的操作。

要点

  • PCRTO组撤机试验时长显著短于AV桥接组(中位88.0 vs 196.6分钟,P<0.001)。
  • PCRTO安全、简单、可重复,避免了对ECMO管路的操作。
  • PCRTO适用于多种心脏与非心脏适应症,便于多次撤机尝试。

核心结论

  • PCRTO是VA-ECMO撤机时保留管路进行撤机试验的安全、简单、可重复的方法。
  • 本研究中PCRTO组撤机试验时长显著短于AV桥接组。

研究设计与样本

  • 回顾性研究,纳入2014年11月至2018年4月间使用PCRTO或AV桥接从VA-ECMO撤机的全部患者。

主要发现

  • ECMO适应症包括心脏病因(PCRTO组n=16,AV桥接组n=11)和非心脏病因(PCRTO组n=15,AV桥接组n=9)。
  • 每组各死亡1例。
  • 撤机试验时长PCRTO组显著短于AV桥接组(中位88.0 vs 196.6分钟,P<0.001)。
  • 试验期间有2例从PCRTO转为AV桥接(一例为Norwood术后2.9kg新生儿,一例为2.2kg心脏异位修复术后患者)。

临床怎么用

  • PCRTO可作为VA-ECMO撤机试验的首选方法,避免管路操作并缩短试验时间。
  • PCRTO提供撤机试验期间的“应激测试”以评估心肺储备,适用于多种心脏与非心脏适应症。
  • PCRTO便于多次撤机尝试,但低体重婴幼儿(如Norwood术后)可能需转为AV桥接。

局限性

  • 回顾性研究,样本量有限(共51例)。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of the study is to compare a technique of pump-controlled retrograde trial off (PCRTO) to insertion of an arterio-venous (AV) bridge to conduct a trial from venoarterial extracorporeal membrane oxygenation (VA ECMO). METHODS: We studied all patients who were weaned from VA ECMO using either PCRTO or AV bridging from November 2014 to April 2018. Demographic data, indications for ECMO, duration of ECMO, duration of trial period off ECMO and survival were compared between the 2 groups. RESULTS: Seventy-nine patients were placed on VA ECMO from November 2014 to April 2018, of whom, 51 (65%) patients met the study inclusion criteria: 31 (61%) patients who had a trial period from VA ECMO using PCRTO and 20 (39%) patients who were weaned using an AV bridge. The indications for ECMO included cardiac (n = 16 and 11, respectively) and non-cardiac aetiologies (n = 15 and 9, respectively). There was 1 death in each group. The duration of the trial off VA ECMO was significantly shorter in the PCRTO group (median = 88.0 vs 196.6 min, P < 0.001). There were 2 conversions from PCRTO to AV bridging during the trial period off ECMO (2.9-kg neonate following a Norwood procedure and 2.2-kg patient following repair of ectopia cordis). CONCLUSIONS: PCRTO is a safe, simple and reproducible approach for enabling a trial period while preserving the circuit during weaning from VA ECMO. In our study, the duration of the trial period off VA ECMO was significantly shorter in the PCRTO group. PCRTO avoids manipulation of the ECMO circuit, provides a 'stress test' to evaluate cardiorespiratory reserve during the trial period off ECMO, is applicable for a wide variety of cardiac and non-cardiac indications and facilitates multiple attempts at weaning from ECMO.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Pandya NR, Daley M, Mattke A, et al. A comparison of pump-controlled retrograde trial off to arterio-venous bridging for weaning from venoarterial extracorporeal membrane oxygenation. Eur J Cardiothorac Surg. 2019. PMID: 30698769. doi:10.1093/ejcts/ezy485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。